(MedPage Today) — The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in adults with alkaptonuria, Cycle Pharmaceuticals announced on Thursday.
Alkaptonuria is an ultra-rare hereditary disorder of tyrosine…
Source link : https://www.medpagetoday.com/primarycare/generalprimarycare/116173
Author :
Publish date : 2025-06-20 19:07:00
Copyright for syndicated content belongs to the linked Source.
